Development of a Murine Model for Femoral Artery Anastomotic Stenosis
April 18th, 2025
Here we present a murine model for femoral artery anastomosis, offering researchers a valuable animal model to study and simulate vascular anastomotic stenosis. This development is crucial for advancing our understanding of the pathophysiology underlying this condition and facilitating more accurate and effective research into vascular diseases.
Our study introduces an enhanced mouse femoral arterial model for investigating anastomotic restenosis. We place particular emphasis on surgical accuracy to delve deeper into the mechanisms of intimal hyperplasia and hemodynamic impacts, ultimately aiming to facilitate clinical application.
Achieving consistent surgical prioritization in small murine blood vessels can be quite challenging. The elasticity of the vessel walls can lead to retraction and collapse during anastomosis, making it tough to ensure proper alignment and secure sutures.
Careful surgical techniques help maintain the integrity of the epithelium, leading to a decrease in postoperative complications. This also allows for accurate blood flow analysis and provides harmless blood vessel research and procedure.
[Narrator] To begin, position an anesthetized mouse in a supine position on a surgical platform, ensuring the hind limbs are extended without overstretching. Gently grasp the mouse's toe with forceps to confirm that the mouse is fully anesthetized. Apply a depilatory cream to the thigh area for one minute, then clean the area thoroughly to remove any residual cream and stray hairs. Disinfect the surgical site with iodine solution and alcohol three times to prepare for the procedure. Under a stereo microscope, make a 1.5 centimeter long incision along the axis of the femur in the mid thigh region using a micro scalpel. Perform blunt dissection to separate the subcutaneous tissue until the femoral artery and femoral vein are exposed. Carefully dissect the tissue to fully expose a one centimeter section of the femoral artery. Using hemostatic forceps, gently separate the muscles and deep fascia to reveal the nerves, artery and vein. Next, gently separate the femoral artery and femoral vein using blunt dissection. Use fine forceps to carefully remove the connective tissue, fully exposing the femoral artery. Place a sterile pad beneath the femoral artery to prevent accidental needle injury. Clamp the femoral artery with forceps to induce a hematoma. Now use small hemostatic forceps to clamp the proximal and distal ends of the femoral artery. Use fine scissors to neatly and symmetrically transect the femoral artery. Gently scrape the blood vessels with curved forceps to allow the residual blood to flow out. To provide support during suturing and simulate potential damage caused by guide wire intervention, insert a one centimeter long 6-0 nylon surgical suture into the femoral artery. Ensure proper alignment and smoothness of the artery for suturing. Use a 12-0 nylon surgical suture for anastomosis. Adjust the needle angle under the microscope to ensure the needle exits from the inner side to the outer side of the vessel. Create six puncture sites, three on the proximal and three on the distal ends of the femoral artery. Cut four lengths of the 12-0 nylon surgical suture, each measuring three to four centimeters. Thread each suture through the corresponding puncture hole. Begin with a loose knot to avoid tangling. Remove the 6-0 nylon surgical suture used for vessel support and securely tie the knots. Release the hemostatic forceps after completing the anastomosis. Gently scrape the femoral artery with curved forceps from the proximal to the distal end to check for patency. Ensure that blood flows freely through the vessel and inspect the anastomosis site for any signs of leakage. Now suture the skin of the lower limb using a 6-0 nylon surgical suture in an interrupted pattern. Significant intimal hyperplasia was observed in the vascular anastomosis group compared to the control group, confirming successful vascular remodeling. The intimal to medial area ratio was significantly higher in the vascular anastomosis group compared to the control group, indicating increased intimal thickening. Immunohistochemical staining showed increased alpha-SMA expression in the vascular anastomosis group, suggesting smooth muscle cell proliferation. CD31 expression was observed in both groups, confirming endothelial presence, with a difference in staining intensity between groups.
View the full transcript and gain access to thousands of scientific videos
Overview
This study introduces an enhanced mouse femoral arterial model for investigating anastomotic restenosis. It emphasizes surgical accuracy to explore the mechanisms of intimal hyperplasia and hemodynamic impacts.
Key Study Components
Area of Science
- Vascular biology
- Animal models
- Surgical techniques
Background
- Vascular anastomotic stenosis is a significant clinical issue.
- Understanding the pathophysiology is crucial for effective treatment.
- Challenges exist in achieving consistent surgical outcomes in small vessels.
- Intimal hyperplasia is a key factor in restenosis.
Purpose of Study
- To develop a reliable murine model for studying vascular anastomosis.
- To investigate the mechanisms leading to intimal hyperplasia.
- To facilitate clinical applications of surgical techniques.
Methods Used
- Creation of a murine model for femoral artery anastomosis.
- Focus on surgical precision during the procedure.
- Assessment of hemodynamic impacts post-surgery.
- Evaluation of intimal hyperplasia development.
Main Results
- Successful establishment of a murine model for vascular studies.
- Identification of factors affecting surgical outcomes.
- Insights into the mechanisms of intimal hyperplasia.
- Potential for improved surgical techniques in clinical settings.
Conclusions
- The murine model provides a valuable tool for vascular research.
- Enhanced understanding of anastomotic stenosis mechanisms.
- Future studies can build on this model for clinical applications.
Frequently Asked Questions
Executive Industry Relevance
Reliable murine models for femoral artery anastomotic stenosis are critical for de-risking early vascular target hypotheses and understanding restenosis mechanisms. This refined model enables reproducible investigation of intimal hyperplasia and vascular remodeling, supporting predictive confidence in preclinical vascular intervention studies. Enhanced reproducibility and technical standardization directly impact translational research and therapeutic evaluation pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic interrogation of vascular injury and repair pathways relevant to restenosis.
- Supports biological de-risking by modeling intimal hyperplasia and smooth muscle proliferation.
- Facilitates functional target validation for vascular remodeling interventions.
Screening & Assay Development
- Provides a standardized in vivo system for evaluating anti-restenotic compounds.
- Improves assay reproducibility through refined surgical and handling techniques.
- Generates quantitative outputs such as intimal/medial area ratios and immunohistochemical markers.
Translational & Preclinical Research
- Aligns preclinical models with disease-relevant vascular remodeling endpoints.
- Enables continuity from mechanistic discovery to therapeutic intervention assessment.
- Supports risk-adjusted advancement of vascular candidates based on robust in vivo data.
Pipeline & Workflow Integration
This model integrates into the discovery-to-preclinical continuum for vascular disease, bridging mechanistic studies and therapeutic evaluation.
- Discovery Biology: Supports hypothesis testing on intimal hyperplasia and endothelial repair mechanisms.
- Screening: Delivers reproducible, quantitative readouts for compound efficacy assessment.
- Analytics: Enables measurement of vessel patency, intimal thickening, and marker expression for comparative analysis.
- Translational Research: Provides a foundation for evaluating intervention strategies in a disease-relevant context.
- Enterprise Reuse: Offers a validated, scalable model for ongoing vascular research and cross-program support.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in vascular target validation and mechanistic de-risking.
- Operational Value: Enhances reproducibility and standardization of in vivo vascular studies.
- Strategic Value: Informs go/no-go decisions for vascular intervention programs with robust preclinical data.
- Portfolio Impact: Enables risk-adjusted prioritization of vascular therapeutic candidates.
Implementation Considerations
- Requires microsurgical expertise and precise vascular handling skills.
- Demands access to stereomicroscopy and specialized surgical instrumentation.
- Necessitates cross-team standardization of surgical protocols and analytical endpoints.
- Adaptation may be needed for different vascular beds or disease models.
- Model throughput is limited by technical complexity and operator proficiency.
